Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Hyperthermia × Doxorubicin × Clear all

Phase

Status

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 165 Lymphoma, Large B-Cell, Diffuse 90 Lymphoma 90 Precursor Cell Lymphoblastic Leukemia-Lymphoma 72 Sarcoma 60 Hodgkin Disease 50 Lymphoma, Non-Hodgkin 35 Triple Negative Breast Neoplasms 33 Burkitt Lymphoma 33 Leukemia 31 Lymphoma, Mantle-Cell 30 Lymphoma, Follicular 28 Carcinoma, Hepatocellular 26 Multiple Myeloma 23 Ovarian Neoplasms 19 Neoplasms 18 Neoplasm Metastasis 18 Prostatic Neoplasms 17 Osteosarcoma 16 Lymphoma, Large-Cell, Anaplastic 16 Lymphoma, B-Cell 14 Neuroblastoma 13 Lymphoma, Large-Cell, Immunoblastic 13 Urinary Bladder Neoplasms 12 Lymphoma, T-Cell, Peripheral 12 Immunoblastic Lymphadenopathy 12 Inflammatory Breast Neoplasms 11 Stomach Neoplasms 10 Recurrence 10 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 9

Interventions

Diathermy 17 Radiotherapy 10 Drug Therapy 4 Cisplatin 4 Radiation 3 Immune Checkpoint Inhibitors 3 Fluorouracil 3 Brachytherapy 3 tislelizumab 2 Surgical Procedures, Operative 2 Immunotherapy 2 Conization 2 spartalizumab 1 anlotinib 1 Solutions 1 Radiation Dose Hypofractionation 1 Patient Reported Outcome Measures 1 Paclitaxel 1 Mitomycin 1 Ifosfamide 1 Hyperthermic Intraperitoneal Chemotherapy 1 Hyperthermia, Induced 1 Hydrogen Peroxide 1 Gemcitabine 1 Folfox protocol 1 Doxorubicin 1 Docetaxel 1 Dacarbazine 1 Cytoreduction Surgical Procedures 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06835049 2025-12-30

TNT-HYPE

Swiss Cancer Institute

Phase 2 Recruiting

Hyperthermia, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡